Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

History of Capital

The table below provides an overview of the history of the company’s share capital since its incorporation on May 30, 2006.

Date Transaction Number of shares issued Issue price per share (€) Capital Increase (€) Issue Premium paid (€) Share capital
after transaction (€)		 Aggregate number of shares
after transaction
May 30th 2006 Incorporation 11.124 5,57 - - 62.000,00 11.124
July 5th 2006 Contribution
in kind		 14.351.403 4.50 64.581.313,50 - 64.643.313,50 14.362.527
July 7th 2006 Capital increase in cash 7.777.778 4.50 35.000.001,00 - 99.643.314,50 22.140.305
May 9th 2007 Capital increase in cash 2.214.030 4.50 9.964.329,20 13.947.194,80 109.607.643,70 24.354.335
Sept 13th 2007 Exercise of warrants 1.147.825 4.50 5.165.212,50 1.699.937,50 114.772.856,20 25.502.160
April 8th 2008 Exercise of warrants 172.629 4,50 776.919,43 86.225,57 115.549.775,63 25.674.789
Oct 10th 2008 Exercise of warrants 56.000 4,50 252.028,85 103.171,15 115.801.804,48 25.730.789
April 9th 2009 Exercise of warrants 38.000 4,50 171.019,58 70.580,42 115.972.804,48 25.768.789
April 30th

2009

 Exercise of warrants 559.000 4,45 2.487.550,00 - 118.460.374,06 26.327.789
Oct 5th 2009 Exercise of warrants 90.000 4,50 404.949,83 231.420,17 118.865.323,89 26.417.789
Nov 20th 2009 Capital increase in cash 2.641.778 4,50 11.886.528,34 30.381.919,66 130.751.852,23 29.059.567
March 22nd 2010 Exercise of warrants 96.667 4,50 434.947,62 139.431,93 131.186.799,85 29.156.234
Oct 22nd 2010 Exercise of warrants 289.000 4,50 1.300.338,90 1.544.511,10 132.487.138,75 29.445,234
Dec 8th, 2010 Capital increase in cash 2.944.523 4,50 13.248.712,08 42.697.224,92 145.735.850,83 32.389,757
March 25th 2011 Exercise of warrants 24.000 4,50 107.986,63 65.353,37 145.843.837,46 32.413,757
October 28th 2011 Exercise of warrants 33.000 4,50 148.481,61 198.088,39 145.992.319,07 32.446.757
April 3rd, 2012 Capital increase in cash 3.244.675 4,50 14.599.228,76 63.272.971.24 160.591.547,83 35.691.432
May 21, 2012 Exercise of warrants 121.917 4,50 548.558,54 834.573,51 161.140.106,37 35.813.349
October 17, 2012 Exercise of warrants 46.875 4,50 210.911,37 481.096,13 161.351.017,74 35.860.224
April 25, 2013 Exercise of warrants 234.125 4,50 1.053.431,99 1.907.560,51 162.404.449,73 36.094.349
January 5, 2018 Capital increase in cash 2,177,226 4,50 9.796.303,31 203.696,69 172.200.753,04 38.271.575
June 1, 2018 Capital decrease - - -24.302.544,14 -157.864.957,06 147.898.208,90   38.271.575
November 8, 2018            Exercise of warrants 20.375 3,86   78.737,97  12.949,53 147.976.946,87    38.291.950